ತೀವ್ರವಾದ ರಕ್ತದ ಅಸ್ವಸ್ಥತೆ (ಸಾಮಾನ್ಯವಾಗಿ ವಿಕಿರಣ ಅಥವಾ ಔಷಧ ಚಿಕಿತ್ಸೆಯಿಂದ ಉಂಟಾಗುತ್ತದೆ),

agranulocytosis's Usage Examples:

is associated with a relatively high risk of low white blood cells (agranulocytosis), a condition of suppressed immunity which may result in death.

syndrome, nephrotoxicity, hepatitis, aplastic anemia, neutropenia, or agranulocytosis.

analgesic, anti-inflammatory, and antipyretic properties but has risk of agranulocytosis.

1988 the drug was withdrawn from the market in Spain due to risk of agranulocytosis; other countries where the drug was available added warnings to the.

Due to the risk of agranulocytosis its use as a drug is discouraged.

Basopenia (or basocytopenia) is a form of agranulocytosis associated with a deficiency of basophils.

cause: anaphylaxis, angiooedema, anaemia, agranulocytosis, eosinophilia, leucopenia, pancytopenia, vasculitis, toxic epidermal necrolysis, Stevens–Johnson.

perhaps due to its capacity for producing potentially life-threatening agranulocytosis, similarly to clozapine, which it closely resembles both structurally.

include eosinophilia and blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia); reversible.

Less common but more serious side effects are agranulocytosis (very low levels of granulocytes, a type of white blood cell) and neutropenia.

Acquired agranulocytosis is.

Less commonly Stevens–Johnson syndrome, toxic epidermal necrolysis, agranulocytosis, liver failure, anaphylaxis, etc.

As with other sulfonamides, there is a significant risk of agranulocytosis, and this, rather than the development of resistance by bacteria, is.

Synonyms:

granulocytopenia, blood disorder, blood disease, agranulosis,

Antonyms:

hypervolemia, hypovolemia,